The Leprosy Mission

Last updated
A leprosy patient receives restorative hand surgery in India Restorative hand surgery Leprosy Mission International India.jpg
A leprosy patient receives restorative hand surgery in India

The Leprosy Mission (TLM) is an international and inter-denominational Christian medical organisation focused on the treatment and eradication of Hansen's disease, commonly known as leprosy. Their operational focus is on healthcare delivery, rehabilitation, advocacy, and rights-based approaches in endemic communities. [1] As the disease is now both treatable and preventable, TLM works globally towards: zero leprosy transmission, zero disability, and zero discrimination for people affected by the disease.

Contents

Global operations

The Leprosy Mission works through a Global Fellowship, composed of Members and Affiliates from 29 different countries. [2] It is organised into four global areas of operations, some which focus implementing leprosy work, others which concentrate on raising funds.

1. Europe

The Leprosy Mission lists Belgium [3] Denmark [4] Finland [5] France [6] Germany [7] Great Britain [8] Hungary [9] Netherlands [10] Northern Ireland [11] Norway [12] Spain [13] Sweden [14] and Switzerland [15] as either members or affiliates in its Global Fellowship. These are focused on raising funds for the global work. [16] [17]

Countries where the Leprosy Mission is active as of 2025 TLM 2025 world operations map with legend.png
Countries where the Leprosy Mission is active as of 2025

2. Africa

TLM has teams teams in Chad, DR Congo, Ethiopia, Mozambique, Niger and Nigeria. [18] [19] It directly operates its own hospitals in many of these countries, where the lines of effort are on active case detection, training people for self-care groups, and outpatient care integrated with clinical services. [20] [21]

3. Asia

Across Asia, TLM operates in Bangladesh, East Timor, India, Myanmar, Nepal and South Korea. Here, they run specialist hospitals and clinics, deliver surgery and ulcer care, operates large outpatient services and patient helplines, conduct clinical research, and support community outreach along with disability-inclusion projects. [22] [23] [24] [25] [26]

4. Oceania

In Oceania, the Leprosy mission implements health programs in Kiribati and Papua New Guinea. [27] [28] The national committees in Australia and New Zealand primarily focus on generating support. [19] [29]

Areas of work

Hospitals and healthcare

An occupational therapy clinic in India. Occupation therapy to rehabilitate patients with leprosy in India.jpg
An occupational therapy clinic in India.

The Leprosy Mission owns 14 hospitals in India, one in Bangladesh, and one in Nepal. [30] [22] [31] TLM-affiliated hospitals provide specialist tertiary care, including reconstructive surgeries, along with the treatment of leprosy itself. [32] They also serve as centres for training, both for doctors and paramedics, in matters such as early detection. [33]

Once trained, local doctors and nurses at these hospitals treat ulcers and leprosy reactions, providing counselling, mental health support, and health education, much of which also forms the basis for medical research. [34] [35] They also provide reconstructive surgery, physiotherapy, assistive devices, and special footwear. In 2022, 1,335 people underwent reconstructive surgery with The Leprosy Mission. [36] [37] Allied health professionals, connected to centres such as in Nigeria and Myanmar, serve in mobile prosthetic units in that provide medical care to those who have lost their limbs. [38] [39] All of this is designed to enable people affected by leprosy towards self-reliance and independence. [40]

The Leprosy Mission also supports a number of hospitals in Asia and Africa that are owned by the government or local church. For example, the Mawlamyine Christian Leprosy Hospital in Myanmar and the Qua Iboe Church Hospital in Ekpene Obom partners with LMI for surgical support. [41] [42] Equally, Nigerian state owned hospitals in the states of Kano, Sokoto and Niger States also work in partnership with LMI for medical treatment resources. [42]

Community-based rehabilitation

People affected by leprosy are often socially ostracised, which prevents them from being able to participate in the economic, social, and political life of the society in which they live. [43] [44] This, in spite of the fact the disease is now proven to be difficult to catch even from close contact and, in the early stages, straightforward to treat. [45]

To tackle this issue, The Leprosy Mission supports community-based rehabilitation programmes, particularly across Asia and Africa. [46] [47] This work includes promoting inclusive development, skills training, micro-finance, self-help groups, low-cost housing, self-care groups, and supporting Disabled People's Organisations. [46] Self-help groups have been proven to reduce the experience of stigma, increase well-being, and enhance household economic performance. [48] The Leprosy Mission also campaigns to end legal discrimination against people affected by leprosy [26] and encourages community support for those affected. [49] A good example of this has been community‑based rehabilitation in Nepal which has involved small‑scale grants for businesses and scholarships for leprosy‑affected individuals. [50]

Training and education

Graduation of paramedics in Northern India, 1977 Graduation of paramedics, Richardson Leprosy Mission, India, 1977 (16387261504).jpg
Graduation of paramedics in Northern India, 1977

Historically, LMI has been closely linked—through partners and affiliate institutions—to training a wide range of healthcare workers. A leading example is through The Leprosy Mission Trust India, whose hospitals are recognised by government, not only for reconstructive surgery and rehabilitation, but for training of doctors, allied health professionals, cascading down to frontline staff. [51]

Leprosy is found predominantly in countries where poverty is widespread, and correlates with low education, food insecurity, poor housing, and lack of sanitation. [52] To help prevent poverty amongst the leprosy community, The Leprosy Mission provides education to people affected by leprosy, offering formal education and literacy classes. [53]

For school-age children, The Leprosy Mission will provides support to help them to stay in school and finish their school education. In a 2024 project in Bangladesh, 100 students from vulnerable families affected by leprosy were sponsored to pursue higher education and they, in turn, provided free coaching services to 498 primary and high school students as well as non-formal education to 210 adults. [54] For adults in Africa, The Leprosy Mission has supported programs offering vocational training in computing, agriculture, car mechanics and printing. [55]

The Leprosy Mission, as part of its work within the International Federation of Anti-Leprosy Associations, conducts training programmes for general health care workers. These sessions are designed to strengthen early recognition of the clinical signs of leprosy, ensure correct administration of multi-drug therapy (MDT), and thereby reduce the risk of further transmission within communities. [56]

Partner organisations also engage in community awareness campaigns. For example, in Mozambique (through the “Mission Zero” project) and in India (Chhattisgarh), efforts have focused on increasing local leprosy awareness, reducing stigma, and promoting early detection. Additionally, World Leprosy Day campaigns—organised by ILEP’s member institutions—serve as nationally and internationally visible platforms for public education on leprosy. [57] [19]

Advocacy

A patient being treated in Cuddalore District, India PARTI Project Cuddalore District TLMA cr DC ffa407d4-9762-4db6-9a83-a628d0c35a93.jpg
A patient being treated in Cuddalore District, India

Advocacy has been shown to reduce stigma, raise community awareness, which, in turn, encourage people to seek treatment for leprosy earlier. [58] [59] The Leprosy Mission works alongside persons affected by leprosy so that they can advocate both for awareness of the condition, for their rights, and to ensure they face fewer physical and social barriers, as well as removing legal to participating in society. [60] The advocacy of the partner movement in India led to repeals of archaic laws where leprosy was grounds for divorce. [61]

TLM and its partners advocate with communities by creating and supporting self-help groups. This is demonstrated to increase the health literacy and confidence of participants. [62] Under community leadership; over time, this shifts from NGO-led advocacy to self-advocacy by people affected by leprosy—a pattern evidenced in Nepal and India and reinforced by legal-rights advocacy. [63] [64] The program in Chhattisgarh, India, was shown to encourage women to become more self-sufficient, including participation in the workforce, along with successful reforms to local government. [65]

The Leprosy Mission has worked with the United Nations to pressure member states to protect the rights of people affected by leprosy. [66] This advocacy is based on the UN Convention on the Rights of Persons with Disabilities. [66] At the national level, TLM works with national governments to ensure that leprosy receives the appropriate time, attention, and resources. These activities aim to press governments to repeal discriminatory laws and to follow UN Human Rights Council and General Assembly guidance on ending leprosy-related discrimination. [67]

The Leprosy Mission also advocates for sustained government support, as reductions in leprosy cases have lead governments to prematurely declare the crisis resolved. [68] However, once funding is removed, resurgences in transmission have followed. [69]

Ensuring access to MDT (multi-drug therapy) is a focused area of activity for TLM. In Nigeria, a stated concern is for "leprosy patients who belong to the poorest of the poor are not able to access this life-saving medication." [70] Here, advocacy begins within the local health systems, ensuring early recognition of the clinical signs of leprosy, and that multi-drug therapy is provided. [33]

Research

Research in the 1950s led to Multidrug Therapy, now a cornerstone of healthcare strategies for leprosy. Kothara Hospital pharmaceuticals TLMI cr DC 38d17c8f-1ed8-4bca-bdf5-5cc19b87283f.jpg
Research in the 1950s led to Multidrug Therapy, now a cornerstone of healthcare strategies for leprosy.

The Leprosy Mission’s commitment to research spans decades, with its community of clinicians delivering key treatment breakthroughs in the 1960s to 1980s.

Dr Paul Brand and his wife Dr Margaret Brand joined the staff of The Leprosy Mission in 1953, going on to lead a dedicated research team for 30 years. The Brands pioneered the discovery that the loss of fingers and toes amongst people with leprosy was, in fact, due to infection and therefore preventable. [71] He went on to innovate reconstructive surgery for leprosy-related disability, largely working in TLM partnered hospitals in India. [72]

Stanley G. Browne was a lifelong medical missionary and later medical consultant to The Leprosy Mission. A prolific scientist, he publishing “some 500 articles” across leprosy and tropical medicine. [73] Working with Dr John Lowe, also serving with the Mission, Browne made early therapeutic investigations into the use of sulfone drugs, such as dapsone, which were found could stop Mycobacterium leprae from multiplying. [74] In the 1950s, Browne conducted therapeutic trials of clofazimine. [75] It proved effective both as an anti-microbial and as an anti-inflammatory agent, particularly helpful in controlling erythema nodosum leprosum (ENL), a painful leprosy reaction. [76] Both these drugs were later incorporated into multidrug therapy which is regarded as "the principal catalyst for achieving grew from trials combining rifampicin, dapsone, and clofazimine. [75] [77] In the view of the World Health Organisation, this multi-drug therapy "proved spectacularly effective." [78]

More recent research has gone into drug resistance in leprosy resulting from genetic mutations in bacterial strains. [79] Around 70% of people affected by leprosy may struggle with mental illness (anxiety or depression), [80] so The Leprosy Mission also works to understand the link between leprosy and personal wellbeing. Research continues in the Mycobacterial Research Laboratory in Anandaban Hospital, Nepal, [81] at the Rural Health Programme, Nilphamari, Bangladesh, [82] and at the Stanley Browne Laboratory in New Delhi, India. [83]

Strategy and goals

Leprosy is a curable disease and if cases can be diagnosed and treated early enough, the disabilities associated with leprosy can be avoided. [84] The Leprosy Mission continue to reduce the number of new leprosy cases, working toward zero cases by 2035. [85] Their research program aims to learn more about giving an early diagnosis, monitoring relapse, and anti-microbial resistance. The Leprosy Mission will also use new technology to support primary and secondary healthcare workers. TLM partners with governments and other leprosy NGOs to identify active cases in the community, then implement contact tracing, and raise awareness amongst local people. [86]

In 2024, Leprosy Mission marked 150 years of fighting leprosy. [87] The Leprosy Mission began with Wellesley Bailey and his wife Alice having regular meetings in Dublin to tell friends about their experiences of people affected by leprosy in India, and to raise money. [88]

Bailey, a Christian from Ireland, had been working as a teacher in the Punjab in India. [89] [90] During this time he had come across a row of huts inhabited by men and women with serious disabilities and physical deformities. His friend Dr Morrison, a leader of the American Presbyterian Mission in Ambala, explained that they were suffering from leprosy. [91] Bailey was shocked by what he saw. Afterwards he wrote: [92]

I almost shuddered, yet I was at the same time fascinated, and I felt that if there was ever a Christ-like work in the world it was to go amongst these poor sufferers and bring them the consolation of the gospel.

In its early decades, the mission was funded by thousands of small denomination donations. [93] While individual donations remain key to its finances, the organisation receives substantial funding from government agencies, such as the Foreign, Commonwealth and Development Office in the UK and Department of Foreign Affairs and Trade in Australia. [94] [95]

History

Nineteenth Century Wood engraving of missionaries and patients at the Lepers Mission in India. Three vignettes; a group of lepers, two missionaries and a Wellcome V0010515.jpg
Nineteenth Century Wood engraving of missionaries and patients at the Lepers Mission in India.

The Leprosy Mission was founded by a Irish teacher, Wellesley Bailey in 1874. [93] [96] Over time, its missionary-run leprosy asylums emerged as hybrid institutions—healthcare delivery centres shaped by global medical advances—particularly tropical medicine—and religious caregiving models. [97] Religious care was the primary motivation for Bailey, as he compared the helplessness of the sick with "the way sinners have to come to God and get His blessing". [97] Originally known as the Mission to Lepers in India, the organisation had 10 asylums and supported 8 others by 1893; in 1899 it maintained 19 asylums, and aided many others. [97] Largely, the work spread according to the presence of the British Empire, though it would also come to serve in China and Thailand. [93]

1874–1893 – The Baileys travel extensively in India to see the need of people affected by leprosy and to encourage support work and donations, and establish a clinic in Punjab to bring medical relief to leprosy patients. [98]

1891 – Wellesley Bailey visits Mandalay, Burma, to open the first MTL home for leprosy-affected people outside India.

1891 – mission in Hangzhou, in Zhejiang, China, established on Saint Andrew's Day. This later extended to seven centres in Fujian, then in Guangdong. By 1914 this extended further to missions in Shandong. A colony established in Dajin Island, in the South China Sea, was funded by the American Mission to Lepers, who also supported an initiative at Stone Gateway, Yunnan. In 1920 an HQ for the work in China was created in Shanghai. [99] The Leprosy Mission began a partnership in 1925, including a building program for medical training facilities, with Shantung Christian College, later known as Cheeloo University. [99]

1910s – The Mission has extended its work throughout India and the Far East and now has 87 programmes in 12 countries, with support offices in eight countries, including the auxiliary which would become Leprosy Mission Australia. [100]  .

1930s – MTL began to develop into a medical mission with the vision to help eradicate leprosy. In 1930 it was working in 100 centres across 15 nations, though most of their work was in India. [101]

1940s – In South India, Paul Brand pioneers medical research and reconstructive surgery on leprosy deformities in hands and feet.

1940s-50s – The first effective cure for leprosy, Dapsone, is introduced. Over the next 15 years, millions of patients are successfully treated. [102] [103]

1950s – TLM's work is extended into Africa. [104]

1954World Leprosy Day is founded by Raoul Follereau, a French writer, to make sure that people everywhere know that leprosy still exists and is completely curable. It is held each year on the last Sunday in January.

1960s – Leprologists work to discover new drugs that are effective against leprosy as many people are discovered to have Dapsone-resistant leprosy.

1965 – Group changes its name from 'The Mission to Lepers' to 'The Leprosy Mission' to avoid the negative connotations of the word ‘leper,’ which is now understood to be a derogatory word' [105]

1970s – TLM begins to extend its work to people's homes and communities, rather than just hospitals and asylums.: 107 

1980Vincent Barry and his team win the 1980 UNESCO Science Prize for their discovery of anti-leprosy drug clofazimine, developed with the assistance of The Leprosy Mission.

1981World Health Organization (WHO) recommends a new combination drug treatment for leprosy, MDT (Multi Drug Therapy). People are cured in as little as six months.

1986 – Leprosy Mission Nigeria established in 1986, to see "Zero Transmission of Leprosy, Zero Disabilities caused by leprosy and Zero Discrimination of persons affected by leprosy and disabilities". [55]

1990s – As many more people are cured, caring for people with lasting disabilities through social, economic, and physical rehabilitation becomes increasingly important.

2011 – The Leprosy Mission moves away from a centrally-directed regional structure and reformulates as a more decentralised Global Fellowship, the Members of which signed the TLM Charter (see below, under 'Where The Leprosy Mission works').

2017 – An ambitious new goal is set: to see no new cases of leprosy by 2035. This goal was agreed upon by the Members of TLM's Global Fellowship.

2019 – A new global strategy is launched with three priorities: 1) Zero leprosy transmission by 2035; 2) Towards zero leprosy disability; 3) Towards zero leprosy discrimination

2024 – The Leprosy Mission celebrates its 150th anniversary and prepares to launch a new global strategy

References

  1. "THE LEPROSY MISSION INTERNATIONAL - Charity 1076356". prd-ds-register-of-charities.charitycommission.gov.uk. Retrieved 2025-08-04.
  2. "BBC Radio 4 - Radio 4 Appeal, The Leprosy Mission (England and Wales)". BBC. Retrieved 2025-08-26.
  3. "TLM BELGIUM". TLM BELGIUM. Retrieved 2025-09-02.
  4. "Home page". Spedalskhedsmissionen - Danmark. Retrieved 2025-09-02.
  5. "Suomen Lepralähetys ry". Suomen Lepralähetys ry (in Finnish). Retrieved 2025-09-02.
  6. "Mission Lèpre France". Mission Lèpre France (in French). Retrieved 2025-09-02.
  7. "Leben verändern | Lepra Mission e.V." Lepra Mission e.V. (in German). Archived from the original on 2025-08-08. Retrieved 2025-09-02.
  8. "About Us". The Leprosy Mission. Retrieved 2025-09-02.
  9. "Home - Lepramism - Hungary". Lepramism Mission - Hungary. Retrieved 2025-09-02.
  10. "TLM NL: Support for reconstructive surgery and care in 2025". YDTI. Retrieved 2025-09-02.
  11. "Charity Details | The Charity Commission for Northern Ireland". www.charitycommissionni.org.uk. Retrieved 2025-09-02.
  12. "TLM Norge". TLM Norge. Retrieved 2025-09-02.
  13. "Where We Work | ILEP Federation" . Retrieved 2025-09-02.
  14. "The Leprosy Mission Sweden – Leprosy Mission Nigeria". leprosymissionnig.org. Retrieved 2025-09-02.
  15. "Lepra heute. Heilung ist möglich. Lepra-Mission Schweiz" (in German). 2022-05-20. Retrieved 2025-09-02.
  16. "THE LEPROSY MISSION INTERNATIONAL - Charity 1076356". prd-ds-register-of-charities.charitycommission.gov.uk. Retrieved 2025-09-02.
  17. "France". Leprosy Mission International. Retrieved 2025-09-02.
  18. "Leprosy". OHCHR. Retrieved 2025-09-02.
  19. 1 2 3 "Where We Work | ILEP Federation" . Retrieved 2025-08-26.
  20. "Mozambique implementing the Global Leprosy Strategy 2016–2020". www.who.int. Retrieved 2025-09-02.
  21. "2,500 new cases of leprosy discovered in Nigeria annually - Mission" . Retrieved 2025-09-02.
  22. 1 2 Begum, Thaslima; Ahmed, Kaamil (2023-04-07). "'Spreading faster than ever': Bangladesh's tea pickers have world's highest rate of leprosy". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-26.
  23. "Timor Leste | ILEP Federation" . Retrieved 2025-09-02.
  24. Ratcliffe, Rebecca (2019-04-22). "'The harder you look the more you find': Nepal's hidden leprosy". The Guardian. ISSN   0261-3077 . Retrieved 2025-09-02.
  25. "Episode #374: It Takes All Of Us". Insight Myanmar. 2025-08-03. Retrieved 2025-09-02.
  26. 1 2 Dhillon, Amrit (2015-11-10). "People affected by leprosy in India face stigma reinforced by cruel colonial law". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-06.
  27. "Charities Services | Home". register.charities.govt.nz. Retrieved 2025-09-02.
  28. postcourieronline (2018-02-05). "Beating leprosy". Post Courier. Retrieved 2025-09-02.
  29. Flyer for the, New Zealand Leprosy Mission Centennial Medal 1974. A Century of Compassion. New Zealand: The Leprocy Mission.{{cite book}}: CS1 maint: numeric names: authors list (link)
  30. "Christian ophthalmologist leading a leprosy program in India" . Retrieved 2025-08-26.
  31. Moreno, Jennifer (2024-10-03). "Landslides devastate Leprosy Mission's Nepal hospital". www.christiantoday.com. Retrieved 2025-08-26.
  32. Dehghan, Saeed Kamali (2022-01-20). "Nepal hospital trials 'life-changing' treatment for leprosy wounds". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-26.
  33. 1 2 "Leprosy trainings conducted for health professionals". www.who.int. Retrieved 2025-08-26.
  34. "TABLE". University of Birmingham. Retrieved 2025-08-26.
  35. Awale, Sonia (2019-07-12). "New treatment offers hope for Nepal's leprosy patients". nepalitimes.com. Retrieved 2025-08-26.
  36. "The Leprosy Mission Progress Report 2022". turtl.co. Retrieved 2024-02-19.
  37. "Impact of reconstructive surgery (RCS) among leprosy patients: A social appraisal | Infolep". www.leprosy-information.org. Retrieved 2025-08-27.
  38. Salako, Pelumi. "In a Nigerian leprosy colony, residents endure stigma and neglect". Al Jazeera. Retrieved 2025-08-26.
  39. "It Takes All Of Us". Insight Myanmar. 2025-08-05. Retrieved 2025-08-26.
  40. SULEIMAN, Shafa'atu. "Leprosy Mission Empowers Persons With Disabilities In Sokoto – The Whistler Newspaper". thewhistler.ng. Archived from the original on 2025-07-25. Retrieved 2025-08-26.
  41. Doyle, David (2016-03-04). "Myanmar's leprosy village offers outcasts a place to call home". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-26.
  42. 1 2 Udo, Sunday; Chukwu, Joseph; Obasanya, Joshua (5 August 2013). "Leprosy Situation in Nigeria". Leprosy Review. 84 (3): 229–237. doi:10.47276/lr.84.3.229.
  43. A, Dr Dhansree; B, Dr Kiran Kumar; Indira, Dr D.; Singh, Dr T. Rajeev (2024-03-15). "Leprosy and ITS Social Stigma: A Community Perspective". Journal of Population Therapeutics and Clinical Pharmacology. 31 (3): 2532–2339. doi:10.53555/m5yrd589. ISSN   2561-8741.
  44. "Leprosy – a disease of the past? – In pictures". the Guardian. 2016-11-23. ISSN   0261-3077 . Retrieved 2025-08-26.
  45. "The curse of leprosy is not spiritual or medical - it is entirely social". BBC Science Focus Magazine. 2019-04-29. Retrieved 2025-08-26.
  46. 1 2 "All Commitments made by The Leprosy Mission International". International Disability Alliance. Retrieved 2025-08-27.
  47. Nicholls, P. G. (2007). WHO/ILEP technical guide on community based rehabilitation and leprosy. P. G. Nicholls. World Health Organization. ISBN   978-92-4-159615-2.
  48. Shrestha, Dilip; Napit, Indra B.; Ansari, Subi; Choudhury, Sopna Mannan; Dhungana, Bishnu; Gill, Paramjit; Griffiths, Frances; Gwyther, Holly; Hagge, Deanna; Kandel, Shovakhar; Puri, Suraj; Sartori, Jo; Watson, Samuel Ian; Lilford, Richard (2021-05-06). "Evaluation of a self-help intervention to promote the health and wellbeing of marginalised people including those living with leprosy in Nepal: a prospective, observational, cluster-based, cohort study with controls". BMC Public Health. 21 (1): 873. doi: 10.1186/s12889-021-10847-0 . ISSN   1471-2458. PMC   8101219 . PMID   33957899.
  49. Olaiya, Tope Templer (2024-01-27). "Leprosy Mission tasks Nigerians to shun stigmatisation". The Guardian Nigeria News - Nigeria and World News. Retrieved 2025-08-06.
  50. "From social curse to social cure: A self-help group community intervention for people affected by leprosy in Nepal | Infolep". www.leprosy-information.org. Retrieved 2025-08-27.
  51. Darlong, Joydeepa; Govindasamy, Karthikeyan; Ilozumba, Onaedo; Choudhury, Sopna; Shrivastva, Anjali; Griffiths, Frances; Watson, Samuel; Sartori, Jo; Lilford, Richard (2023-10-18). "An evaluation protocol of 'Replicability Model' project for detection and treatment of leprosy and related disability in Chhattisgarh, India". PLOS ONE. 18 (10): e0275763. Bibcode:2023PLoSO..1875763D. doi: 10.1371/journal.pone.0275763 . ISSN   1932-6203. PMC   10584107 . PMID   37851621.{{cite journal}}: CS1 maint: article number as page number (link)
  52. Pescarini, Julia Moreira; Strina, Agostino; Nery, Joilda Silva; Skalinski, Lacita Menezes; Andrade, Kaio Vinicius Freitas de; Penna, Maria Lucia F.; Brickley, Elizabeth B.; Rodrigues, Laura C.; Barreto, Mauricio Lima; Penna, Gerson Oliveira (2018-07-09). "Socioeconomic risk markers of leprosy in high-burden countries: A systematic review and meta-analysis". PLOS Neglected Tropical Diseases. 12 (7): e0006622. doi: 10.1371/journal.pntd.0006622 . ISSN   1935-2735. PMC   6053250 . PMID   29985930.{{cite journal}}: CS1 maint: article number as page number (link)
  53. "THE LEPROSY MISSION INTERNATIONAL - Charity 1076356". prd-ds-register-of-charities.charitycommission.gov.uk. Retrieved 2025-08-27.
  54. "REPORT: Empowering leprosy-impacted communities through education in Bangladesh - Sasakawa Leprosy (Hansen's Disease) Initiative" (in Japanese). 2024-04-25. Retrieved 2025-08-27.
  55. 1 2 Soaga, Olayide (2024-12-20). "Leprosy not a death sentence, curable, preventable - Mission". The Guardian Nigeria News - Nigeria and World News. Retrieved 2025-08-06.
  56. "Leprosy trainings conducted for health professionals". www.who.int. 14 June 2024. Retrieved 2025-08-27.
  57. Mamo, Ephrem; Tsehay, Dareskedar; Hassen, Seid; Getahun, Solomon; Mengiste, Addis; Tadesse, Beletshachew; Tadesse, Tesfaye; Legesse, Mengestu; Bobosha, Kidist (2024-02-23). "Training and Active Case Detection to Prevent Leprosy: Effect on Knowledge, Attitude and Skills of Health Workers on Early Diagnosis of Leprosy in a Leprosy Hotspot District in Ethiopia". Tropical Medicine and Infectious Disease. 9 (3): 51. doi: 10.3390/tropicalmed9030051 . ISSN   2414-6366. PMC   10976019 . PMID   38535876.
  58. Willis, Matthew; Fastenau, Anil; Penna, Srilekha; Klabbers, Gonnie (2024-08-22). "Interventions to reduce leprosy related stigma: A systematic review". PLOS Global Public Health. 4 (8): e0003440. doi: 10.1371/journal.pgph.0003440 . ISSN   2767-3375. PMC   11340997 . PMID   39172813.{{cite journal}}: CS1 maint: article number as page number (link)
  59. Fastenau, Anil; Willis, Matthew; Vettel, Constanze; Stuetzle, Sophie C. W.; Penna, Srilekha; Chahal, Priyanka; Schlumberger, Fabian; Mow, Mowmita Basak; Ekeke, Ngozi; Chukwu, Joseph Ngozi; Deps, Patricia D. (2024-12-03). "Integrating Community Engagement in Zero Leprosy Efforts: A Pathway to Sustainable Early Detection, Control and Elimination". Tropical Medicine and Infectious Disease. 9 (12): 296. doi: 10.3390/tropicalmed9120296 . ISSN   2414-6366. PMC   11679978 . PMID   39728823.
  60. Dhillon, Amrit (2015-11-10). "People affected by leprosy in India face stigma reinforced by cruel colonial law". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-27.
  61. "Lok Sabha passes bill to remove leprosy as ground for divorce". The Times of India. 2019-01-07. ISSN   0971-8257 . Retrieved 2025-08-27.
  62. Shrestha, Dilip; Napit, Indra B.; Ansari, Subi; Choudhury, Sopna Mannan; Dhungana, Bishnu; Gill, Paramjit; Griffiths, Frances; Gwyther, Holly; Hagge, Deanna; Kandel, Shovakhar; Puri, Suraj; Sartori, Jo; Watson, Samuel Ian; Lilford, Richard (2021-05-06). "Evaluation of a self-help intervention to promote the health and wellbeing of marginalised people including those living with leprosy in Nepal: a prospective, observational, cluster-based, cohort study with controls". BMC Public Health. 21 (1): 873. doi: 10.1186/s12889-021-10847-0 . ISSN   1471-2458. PMC   8101219 . PMID   33957899.
  63. Muldoon, Oral (6 October 2020). "Health literacy among self-help leprosy group members reduces stereotype endorsement and stigma-related harm in rural Nepal". Health and Social Care. 2022 (30): 2230–2239. doi:10.1111/hsc.13771. PMC   10078785 . PMID   35224816.
  64. Mishra, Vivek (2023-03-01). "Support system: This Chhattisgarh SHG began to fight leprosy stigma; it has now made women self-sufficient". Down To Earth. Retrieved 2025-08-27.
  65. Mishra, Vivek (2023-03-01). "Support system: This Chhattisgarh SHG began to fight leprosy stigma; it has now made women self-sufficient". Down To Earth. Retrieved 2025-08-27.
  66. 1 2 "The right to work and employment for persons with disabilities in Low and Middle Income Countries: lessons from the front line and what this means for states, the UN and civil society (COSP17 Side Event) | UN Web TV". webtv.un.org. 2024-05-30. Retrieved 2025-08-27.
  67. Nanri, Takahiro (17 March 2022). Zhang, Furen (ed.). "Initiatives to address leprosy as a human rights issue through the mandate of UN Special Rapporteur: Achievements and challenges". PLOS Neglected Tropical Diseases. 16 (3): e0010201. doi: 10.1371/journal.pntd.0010201 . PMC   8929596 . PMID   35299228.{{cite journal}}: CS1 maint: article number as page number (link)
  68. Smith, William Cairns; Brakel, Wim van; Gillis, Tom; Saunderson, Paul; Richardus, Jan Hendrik (2015-04-23). "The Missing Millions: A Threat to the Elimination of Leprosy". PLOS Neglected Tropical Diseases. 9 (4): e0003658. doi: 10.1371/journal.pntd.0003658 . ISSN   1935-2735. PMC   4408099 . PMID   25905706.{{cite journal}}: CS1 maint: article number as page number (link)
  69. Bajaj, Simar (2024-09-30). "'Our new doctors have no clue about leprosy': experts sceptical of India's target to eliminate the disease by 2027". The Guardian. ISSN   0261-3077 . Retrieved 2025-08-25.
  70. Adetayo, Ope; Rigby, Jennifer; Adetayo, Ope; Rigby, Jennifer (2025-03-07). "Nigeria to receive leprosy drugs after a year-long delay". Reuters. Retrieved 2025-08-26.
  71. "Brand, Paul Wilson (1914 - 2003)". livesonline.rcseng.ac.uk. Retrieved 2025-08-27.
  72. "Dr Paul Wilson Brand | International Leprosy Association - History of Leprosy". leprosyhistory.org. Retrieved 2025-08-27.
  73. "Stanley George Browne | RCP Museum". history.rcp.ac.uk. Retrieved 2025-08-27.
  74. "Uzuakoli (Nigeria) | International Leprosy Association - History of Leprosy". leprosyhistory.org. Retrieved 2025-08-27.
  75. 1 2 "Browne, Stanley George (1907 - 1986)". livesonline.rcseng.ac.uk. Retrieved 2025-08-27.
  76. Noordeen, Shaik K. (2016-01-01). "History of chemotherapy of leprosy". Clinics in Dermatology. 34 (1): 32–36. doi:10.1016/j.clindermatol.2015.10.016. ISSN   0738-081X. PMID   26773621.
  77. Sansarricq, H., ed. (2004). "Multidrug therapy against leprosy : development and implementation over the past 25 years" (PDF). World Health Organisation. ISBN   92-4-159176-5.
  78. "Twenty-five years of multidrug therapy for leprosy". www.who.int. Retrieved 2025-08-27.
  79. Lavania, Mallika; Jadhav, Rupendra S.; Chaitanya, Vedithi Sundeep; Turankar, Ravindra; Selvasekhar, Abraham; Das, Loretta; Darlong, Famkima; Hambroom, Ujjwal K.; Kumar, Sandip; Sengupta, Utpal (2014-09-01). "Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India". Leprosy Review. 85 (3): 177–185. doi:10.47276/lr.85.3.177. ISSN   0305-7518. PMID   25509718.
  80. Weiss, Mitchell G.; Doongaji, D. R.; Siddhartha, S.; Wypij, David; Pathare, S.; Bhatawdekar, M.; Bhave, A.; Sheth, A.; Fernandes, R. (1992). "The Explanatory Model Interview Catalogue (EMIC): Contribution to Cross-cultural Research Methods from a Study of Leprosy and Mental Health". The British Journal of Psychiatry. 160 (6): 819–830. doi:10.1192/bjp.160.6.819. ISSN   0007-1250. PMID   1617366.
  81. Bobosha, Kidist; Schip, Jolien J. Van Der Ploeg-Van; Zewdie, Martha; Sapkota, Bishwa Raj; Hagge, Deanna A.; Franken, Kees L. M. C.; Inbiale, Wondmagegn; Aseffa, Abraham; Ottenhoff, Tom H. M.; Geluk, Annemieke (2011-12-01). "Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa". Leprosy Review. 82 (4): 445–458. doi:10.47276/lr.82.4.445. ISSN   0305-7518. PMID   22439283.
  82. Moet, F. Johannes; Pahan, David; Oskam, Linda; Richardus, Jan H. (2008-04-03). "Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial". BMJ. 336 (7647): 761–764. doi:10.1136/bmj.39500.885752.BE. ISSN   0959-8138. PMC   2287265 . PMID   18332051.
  83. Sengupta, Utpal (2018). "Elimination of leprosy in India: An analysis". Indian Journal of Dermatology, Venereology and Leprology. 84 (2): 131–136. doi: 10.4103/ijdvl.IJDVL_1070_16 . ISSN   0973-3922. PMID   29451189.
  84. "Leprosy/Hansen Disease: Management of reactions and prevention of disabilities". www.who.int. Retrieved 2024-02-19.
  85. "Scottish charity in appeal to help leave leprosy in the past". The National. 2021-02-01. Retrieved 2025-08-26.
  86. Richardus, Jan Hendrik; Tiwari, Anuj; Barth-Jaeggi, Tanja; Arif, Mohammad A.; Banstola, Nand Lal; Baskota, Rabindra; Blaney, David; Blok, David J.; Bonenberger, Marc; Budiawan, Teky; Cavaliero, Arielle; Gani, Zaahira; Greter, Helena; Ignotti, Eliane; Kamara, Deusdedit V. (2021-01-01). "Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme". The Lancet Global Health. 9 (1): e81 –e90. doi:10.1016/S2214-109X(20)30396-X. ISSN   2214-109X. PMID   33129378.
  87. Austin, Steve (2024-04-17). "Mornings". ABC listen. 2 hours 11 minutes 50 seconds on. Retrieved 2024-04-23.
  88. Milne, Kenneth (October 2009). "Dictionary of Irish Biography".
  89. "Bailey, Wellesley Cosby | Dictionary of Irish Biography". www.dib.ie. Retrieved 2024-04-23.
  90. Megahey, Alan (2000-08-17). The Irish Protestant Churches in the Twentieth Century. Springer. p. 132. ISBN   978-0-230-28851-5.
  91. Caring Comes First: The Leprosy Mission story, Cyril Davey, Marshall Pickering, 1987, p22
  92. Gandhi, Gopalkrishna (4 September 2016). "Warm, vital, restless". The Telegraph (India).
  93. 1 2 3 Vongsathorn, Kathleen (2012-12-01). "Gnawing Pains, Festering Ulcers, and Nightmare Suffering: Selling Leprosy as a Humanitarian Cause in the British Empire, c. 1890-1960". The Journal of Imperial and Commonwealth History. 40 (5): 863–878. doi:10.1080/03086534.2012.730839. ISSN   0308-6534. PMC   4055987 . PMID   24932060.
  94. "The Leprosy Mission International". GOV.UK. Retrieved 2025-08-06.
  95. "Annual Information Statement 2016". acnc.gov.au. 2016.
  96. Muir, E. (April 1937). "Obituary. Mr. Wellesley C. Bailey" (PDF). Leprosy Review. VIII (2): 63 via ILSL.
  97. 1 2 3 Kakar, Sanjiv (April 1996). "Leprosy in British India, 1860–1940: Colonial Politics and Missionary Medicine" (PDF). Medical History. 40 (2): 215–230. doi:10.1017/S0025727300061019. PMC   1037096 . PMID   8936062 via Cambridge University Press.
  98. Tewari, Kiran (Jan 2019). "Eradicating a Social Stigma : The Leprosy Mission of Almora" (PDF). Journal of Acharaya Narendra Dev Research Institute. 27: 112–120.
  99. 1 2 Anderson, W H P (1930). "The Mission to Lepers". The China Medical Journal: 744–746. doi:10.3760/cma.j.issn.0366-6999.1930.08.102 (inactive 15 August 2025) via MedNexus.{{cite journal}}: CS1 maint: DOI inactive as of August 2025 (link)
  100. Turnbull 1990, p. 5.
  101. "A Dread Disease". Great Southern Herald. 1930-05-10. Retrieved 2024-06-13.
  102. Bennett, Brian H.; Parker, David L.; Robson, Mark (2008-03-01). "Leprosy: Steps Along the Journey of Eradication". Public Health Reports. 123 (2): 198–205. doi:10.1177/003335490812300212. ISSN   0033-3549. PMC   2239329 . PMID   18457072.
  103. Barr, Justin (2011-10-01). "A Short History of Dapsone, or an Alternative Model of Drug Development†". Journal of the History of Medicine and Allied Sciences. 66 (4): 425–467. doi:10.1093/jhmas/jrq068. ISSN   0022-5045. PMID   20966036.
  104. Manton, John (2012-01-01). "Mission, Clinic, and Laboratory: Curing Leprosy in Nigeria, 1945-67".{{cite journal}}: Cite journal requires |journal= (help)
  105. "TLM International | International Leprosy Association - History of Leprosy". leprosyhistory.org. Retrieved 2025-08-27.

Sources

Commons-logo.svg Media related to The Leprosy Mission at Wikimedia Commons